La lecture à portée de main
Découvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDécouvre YouScribe en t'inscrivant gratuitement
Je m'inscrisDescription
Informations
Publié par | Thesee |
Nombre de lectures | 45 |
Langue | English |
Poids de l'ouvrage | 30 Mo |
Extrait
Université de la Méditerranée Aix-Marseille II
Faculté des Sciences de Luminy
Ecole Doctorale des Sciences de la Vie et de la Santé
Thèse
Pour obtenir le grade de
Docteur de l’Université d’Aix-Marseille II
Discipline: Immunologie
Présentée et soutenue publiquement par
Olivier Demaria
Role of Toll-like receptor 8 in the development
of spontaneous autoimmunity in mice
Directrice de thèse: Dr. Lena Alexopoulou
Soutenue le 10 novembre 2010, devant le jury composé de :
Pr. Franck Galland Président
Dr. Bénédicte Manoury Rapporteur
Dr. Vassili Soumelis Rapporteur
Dr. Marc Dalod Examinateur
Dr. Lena Alexopoulou Directrice de thèseTABLE OF CONTENTS
LIST OF ABBREVIATIONS.................................................................................................. 1
RESUME EN FRANÇAIS....................................................................................................... 6
INTRODUCTION.................................................................................................................... 9
1 – PRRs and innate immunity ............................................................................................. 10
1-1 Secreted PRRs................................................................................................................ 12
1-2 Cytosolic PRRs .............................................................................................................. 12
1-3 Transmembrane PRRs ................................................................................................... 16
2-Toll-like receptors ............................................................................................................... 17
2-1 Plasma membrane TLRs ................................................................................................ 19
2-2 Intracellular TLRs.......................................................................... 22
2-3 Intracellular localization and trafficking of nucleic acid sensing TLRs ........................ 26
2-4 Distinct signaling pathways ........................................................................................... 28
2-4-1 MyD88.................................................................................................................... 29
2-4-2 TRIF........................................................................................................................ 30
2-4-3 NF-!B signaling ..................................................................................................... 31
2-5 TLR cooperation............................................................................ 33
3- Adaptive immune system .................................................................................................. 34
3-1 DCs orchestration of conventional lymphocytes ........................................................... 34
3-2 Innate B lymphocytes: MZ and B1 B cells.................................................................... 373-3 Specialization of DC subsets ......................................................................................... 38
4-Autoimmunity and nucleic acid sensing-TLRs ................................................................ 40
4-1 Autoimmunity and tolerance.......................................................................................... 40
4-2 Systemic lupus erythematosus (SLE) ............................................................................ 42
4-3 Autoantibodies ............................................................................................................... 43
4-4 Cell activation by endogenous ligands through endosomal TLRs................................. 45
4-4-1 TLR7 and TLR9 implication in SLE...................................................................... 45
4-4-2 How self-ligand can reach endosomal TLRs.......................................................... 49
4-5 SLE: a disease of TLR-driven amplification ................................................................. 51
4-5-1 TLR-driven B cell activation.................................................................................. 51
4-5-2 TLR-driven pDCs activation 52
4-5-3 TLR-driven cDCs activation 54
4-6 Treatments for SLE........................................................................................................ 54
RESULTS................................................................................................................................ 56
TLR8 deficiency leads to autoimmunity in mice ................................................................. 56
COMPLEMENTARY RESULTS ........................................................................................ 78
1-TLR8 inhibits TLR7 signaling........................................................... 78
-/-2-The reduced MZ B cell population in TLR8 mice is not B cell autonomous .............. 80
3-TLR9 is implicated in the control of TLR7 expression and signaling. .......................... 81
Experimental procedures: ..................................................................................................... 84
DISCUSSION & PERSPECTIVES...................................................................................... 85CONTRIBUTION TO OTHER PUBLICATIONS ............................................................ 95
REFERENCES....................................................................................................................... 98
ANNEXES............................................................. 125
1- Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria
2- Brucella control of dendritic cell maturation is dependent on the TIR-containing
protein Btp1
3- Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient
mice to myocarditis
4- TLR3 and RIG-like receptor on myeloid dendritic cells and RIG-like receptor on
human NK cells are both mandatory for production of IFN-" in response to double-
stranded RNA
5- Gender bias in susceptibility differences to MCMV infection correlates with TLR9
expressionList of abbreviations
LIST OF ABBREVIATIONS
A
AIM2 absent in melanoma 2
ANA antinuclear antibody
AP1 activator protein 1
B
BAFF B cell-activating factor
BCR B cell receptor
BIR baculoviral inhibitor-of-apoptosis-protein repeat
BMDC bone marrow-derived dendritic cell
C
CARD caspase recruitment domain
CD cluster differentiation
cDC conventional DC
CLR C-type lectin receptor
CRD carbohydrate recognition domain
CRP C reactive protein
CTL cytotoxic T lymphocyte
D
DAI DNA-dependent activator of IRFs
DAMP danger associated molecular pattern
DC dendritic cell
DNA deoxyribonucleic acid
dsDNA double-stranded DNA
1List of abbreviations
E
EAE experimental autoimmune encephalomyelitis
EBV Epstein-Bar virus
EMCV encephalo-myocarditis virus
ER endoplasmic reticulum
ERK extracellular regulated kinase
F
FcR! Fc-gamma-receptor
G
CpG cytidine-phosphate-guanosine
H
HEK human embryonic kidney
HMGB high mobility group box
HIV immunodeficiency virus
HSV herpes simplex virus
I
IFN interferon
Ig immunoglobulin
I"B inhibitor of nuclear factor-"B
IL interleukin
iNOS nitric-oxide synthase
IPS-1 IFN# promoter stimulator-1
IRAK IL-1R associated kinase
IRF interferon regulatory factor
2List of abbreviations
J
JNK JUN N-terminal kinase
L
LPDC DC of the lamina propria
LPS lipopolysaccharide
LRR leucine rich repeat
M
MAL MyD88 adaptor like protein
MAPK mitogen activated kinases
MAVS mitochondria antiviral signaling
MBL mannan-binding lectin
MCMV mouse cytomegalovirus
MDA5 melanoma differentiation-associated gene 5
MD2 myeloid differentiation factor 2
MDP muramyl dipeptide
MHC major histocompatibility complex
MyD88 myeloid differentiation primary-response gene 88
MZ marginal zone
N
NAIP neuronal apoptosis inhibitory protein
NALP NACHT, LRR and Pyd containing protein
NF-kB nuclear factor-"B
NLR NOD-like receptor
NK natural killer
NOD nucleotide oligomerization domain
3List of abbreviations
O
ODN olidodeoxynucleotide
OmpA outer membrane protein A
P
pDC plasmacytoid DC
PAMP pathogen-associated molecular pattern
PGN peptidoglycan
Pol III polymerase III
PRAT4A protein associated with TLR4 A
PRR pattern recognition receptor
PTX3 pentraxin 3
PYD pyrin domain
R
RAG recombination-activating gene
RAGE receptor for advanced glycation end-products
REL reticuloendotheliosis viral oncogene homolog
RIG-I retinoic acid-inducible gene I
RIP1 receptor interacting protein-1
RIP2 receptor interacting protein-2
RLR (RIG-I)-like receptor
RNA ribonucleic acid
RNP ribonucleoprotein
RSV respiratory syncytial virus
S
SAP serum amyloid P
siRNA silencing RNA
SLE systemic lupus erythematosus
Sm Smith antigen
SnRNP small nuclear nucleoprotein
4List of abbreviations
ssRNA single-stranded RNA
T
TAK1 transforming-growth-factor-#-activated kinase
TCR T cell receptor
TBK1 TANK binding kinase-1
TGF-#$$ $ transforming growth factor#
tGPI Glycosylphosphatidylinositol-anchored mucin-like